scholarly journals The Combination of MK-2206 and WZB117 Exerts a Synergistic Cytotoxic Effect Against Breast Cancer Cells

2019 ◽  
Vol 10 ◽  
Author(s):  
Yu-Liang Li ◽  
Hao-Cheng Weng ◽  
Jui-Ling Hsu ◽  
Shu-Wha Lin ◽  
Jih-Hwa Guh ◽  
...  
Mastology ◽  
2018 ◽  
Vol 28 (s1) ◽  
pp. 34-34
Author(s):  
André Luiz Silva Oliveira ◽  
◽  
Nicholas Zufelato ◽  
Letícia Reis Silva ◽  
Andris Figueiroa Bakuzis ◽  
...  

2018 ◽  
Vol Volume 11 ◽  
pp. 7669-7677 ◽  
Author(s):  
Maryam Hamzeloo-Moghadam ◽  
Mahmoud Aghaei ◽  
Mohammad Hossein Abdolmohammadi ◽  
Amir Khalaj ◽  
Faranak Fallahian

2020 ◽  
Vol 22 (7) ◽  
Author(s):  
Rita F. L. Ribeiro ◽  
Roberta V. Ferreira ◽  
Davyston C. Pedersoli ◽  
Paulo R. P. Paiva ◽  
Pricila da S. Cunha ◽  
...  

Steroids ◽  
2020 ◽  
Vol 160 ◽  
pp. 108656 ◽  
Author(s):  
Ahmed Ismail ◽  
Ahmed S. Doghish ◽  
Bakheet E. M. Elsadek ◽  
Salama A. Salama ◽  
Amr D. Mariee

Author(s):  
Rollando Rollando

Objective: Ursolic acid was a compound found in Hedyotis corymbosa L., (HCoL) while berberine found in Tinospora crispa (TCa) which are proven to have cytotoxic effect to cancer cells. This research aims to review the effect of cisplatin, ethanolic extract of HCoL and TCa to the sensitivity increase on breast cancer cells, which will be confirmed through apoptosis induction and cell cycle modulation.Methods: The cytotoxic effect was tested using 3-(4,5-dimethylthiazol-2-il)-2,5-diphenyltetrazolium bromide assay on T47D cell using the IC50 parameter. The combination was tested by determining their combination index (CI) and cell viability. The combination effect of apoptosis induction and cell cycle modulation was observed using flow cytometry method.Results: The cytotoxic test result of the combination shows CI value of below 1 at the concentration of HCoL ethanolic extract as much as 1 μg/mL, TCa ethanolic extract as much as 6 μg/mL, and cisplatin as much as 2,5 μM. The combination of HCoL ethanolic extract, TCa ethanolic extract, and cisplatin results in phase S cell accumulation (29.98%) on breast cancer cell T47D and was able to induce apoptosis.Conclusion: The result proves that ethanolic extract of HCoL and TCa can be developed as a cochemotherapeutic agent with cisplatin to increase the effectivity of breast cancer treatment.


2019 ◽  
Vol 46 (6) ◽  
pp. 6205-6213 ◽  
Author(s):  
Amir Asgari ◽  
Sedigheh Sharifzadeh ◽  
Abbas Ghaderi ◽  
Ahmad Hosseini ◽  
Amin Ramezani

2009 ◽  
Vol 20 (8) ◽  
pp. 723-735 ◽  
Author(s):  
Christina W. Yde ◽  
Mathias P. Clausen ◽  
Martin V. Bennetzen ◽  
Anne E. Lykkesfeldt ◽  
Ole G. Mouritsen ◽  
...  

2021 ◽  
Author(s):  
Euphemia Leung ◽  
Petr Tomek ◽  
Moana Tercel ◽  
Johannes Reynisson ◽  
Thomas In Hyeup Park ◽  
...  

The CDK4/6 inhibitor palbociclib, combined with endocrine therapy, has been shown to be effective in postmenopausal women with oestrogen receptor positive, HER2-negative advanced or metastatic breast cancer. However, palbociclib is not as effective in the highly aggressive triple-negative breast cancer that lacks sensitivity to chemotherapy or endocrine therapy. We hypothesized that conjugation of the near-infrared dye MHI-148 with palbociclib can produce a potential theranostic in triple-negative as well as oestrogen receptor positive breast cancer cells. In our study, the conjugate was found to have enhanced activity in all mammalian cell lines tested in vitro. However, the conjugate was cytotoxic and did not induce G1 cell cycle arrest in breast cancer cells suggesting the mechanism of action differed from the parent compound palbociclib. The study highlights the importance of investigating the mechanism of conjugates of near-infrared dyes to therapeutic compounds as conjugation can potentially result in a change of mechanism or target, with an enhanced cytotoxic effect in this case.


Sign in / Sign up

Export Citation Format

Share Document